Photo-Plethysmographic Camera to Monitor Heart Rate, Respiration Rate and Oxygen Saturation in Infants

Sponsor
University of California, Irvine (Other)
Overall Status
Completed
CT.gov ID
NCT00989859
Collaborator
Beckman Laser Institute University of California Irvine (Other)
20
1
3
6.7

Study Details

Study Description

Brief Summary

The researchers want to determine if ambient light, plethysmographic , can monitor reliably heart rate, respiration rate and oxygen saturation in infant patients in a hospital setting.

Condition or Disease Intervention/Treatment Phase
  • Device: Plethysmographic monitoring

Detailed Description

The plethysmographic signal is typically strong on children. This provides a reliable heart rate monitor. However, to measure oxygen saturation, a quantitative value of the strength at two wavelength regions (green and red) is required. It is also not known if the normal ambient light is spectrally appropriate to analyze the video signals for oxygenation. With the current prototype of our system, we can monitor heart rate reliably and estimate oxygen saturation in adults, using normal artificial light or daylight, entering through a window. Heart rate and oxygen saturation will be extracted from the plethysmographic signal off the cheek, forehead or hand while the respiration rate may be retrieved from the plethysmographic signal off the chest area.

Study Design

Study Type:
Observational
Actual Enrollment :
20 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
A Pilot Study Using Photo-plethysmographic (PPG) Camera to Monitor Heart Rate, Respiration Rate and Oxygen Saturation in Infants.
Study Start Date :
Sep 1, 2009
Actual Primary Completion Date :
Dec 1, 2009
Actual Study Completion Date :
Dec 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Plethysmographic monitoring

Plethysmographic monitoring

Device: Plethysmographic monitoring
Plethysmographic monitoring

Outcome Measures

Primary Outcome Measures

  1. ambient light, PPG can monitor reliably heart rate, respiration rate and oxygen saturation (SpO2) [24 hours]

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Minute to 1 Week
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • infant in NICU at CHOC hospital
Exclusion Criteria:
  • non-infant

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHOC Orange California United States 92868

Sponsors and Collaborators

  • University of California, Irvine
  • Beckman Laser Institute University of California Irvine

Investigators

  • Study Director: Stuart Nelson, MD, Beckman Laser Institute University of California Irvine
  • Principal Investigator: William Verkruysse, PhD, Beckman Laser Institute University of California Irvine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Beckman Laser Institute and Medical Center, Willem Verkruysse, Ph.D., Associate Specialist, University of California, Irvine
ClinicalTrials.gov Identifier:
NCT00989859
Other Study ID Numbers:
  • NIH-LAMMP-2009-7046.
First Posted:
Oct 6, 2009
Last Update Posted:
Feb 10, 2017
Last Verified:
Feb 1, 2017
Keywords provided by Beckman Laser Institute and Medical Center, Willem Verkruysse, Ph.D., Associate Specialist, University of California, Irvine

Study Results

No Results Posted as of Feb 10, 2017